The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Nanoemulsion market was valued at US$ 6905.9 million in 2023 and is anticipated to reach US$ 13180 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.
North American market for Nanoemulsion is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nanoemulsion is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Nanoemulsion in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Nanoemulsion include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi and B. Braun Melsungen AG., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nanoemulsion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoemulsion.
Report Scope
The Nanoemulsion market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanoemulsion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanoemulsion companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List):
- Allergan plc
- AbbVie Inc.
- AstraZeneca Inc.
- Fresenius Kabi AG
- Kaken Pharmaceutical Co., Ltd.
- GlaxoSmithKline plc
- Novartis AG
- Sanofi
- B. Braun Melsungen AG.
Segment by Type
- Steroids
- Anesthetics
- NSAIDs
- Immunosuppressant
- Antiretroviral
- Antimicrobials
- Vasodilators
- Others
Segment by Application
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanoemulsion companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanoemulsion Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Steroids
1.2.3 Anesthetics
1.2.4 NSAIDs
1.2.5 Immunosuppressant
1.2.6 Antiretroviral
1.2.7 Antimicrobials
1.2.8 Vasodilators
1.2.9 Others
1.3 Market by Application
1.3.1 Global Nanoemulsion Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanoemulsion Market Perspective (2019-2030)
2.2 Nanoemulsion Growth Trends by Region
2.2.1 Global Nanoemulsion Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanoemulsion Historic Market Size by Region (2019-2024)
2.2.3 Nanoemulsion Forecasted Market Size by Region (2025-2030)
2.3 Nanoemulsion Market Dynamics
2.3.1 Nanoemulsion Industry Trends
2.3.2 Nanoemulsion Market Drivers
2.3.3 Nanoemulsion Market Challenges
2.3.4 Nanoemulsion Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanoemulsion Players by Revenue
3.1.1 Global Top Nanoemulsion Players by Revenue (2019-2024)
3.1.2 Global Nanoemulsion Revenue Market Share by Players (2019-2024)
3.2 Global Nanoemulsion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanoemulsion Revenue
3.4 Global Nanoemulsion Market Concentration Ratio
3.4.1 Global Nanoemulsion Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanoemulsion Revenue in 2023
3.5 Nanoemulsion Key Players Head office and Area Served
3.6 Key Players Nanoemulsion Product Solution and Service
3.7 Date of Enter into Nanoemulsion Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanoemulsion Breakdown Data by Type
4.1 Global Nanoemulsion Historic Market Size by Type (2019-2024)
4.2 Global Nanoemulsion Forecasted Market Size by Type (2025-2030)
5 Nanoemulsion Breakdown Data by Application
5.1 Global Nanoemulsion Historic Market Size by Application (2019-2024)
5.2 Global Nanoemulsion Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nanoemulsion Market Size (2019-2030)
6.2 North America Nanoemulsion Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanoemulsion Market Size by Country (2019-2024)
6.4 North America Nanoemulsion Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanoemulsion Market Size (2019-2030)
7.2 Europe Nanoemulsion Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanoemulsion Market Size by Country (2019-2024)
7.4 Europe Nanoemulsion Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanoemulsion Market Size (2019-2030)
8.2 Asia-Pacific Nanoemulsion Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanoemulsion Market Size by Region (2019-2024)
8.4 Asia-Pacific Nanoemulsion Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanoemulsion Market Size (2019-2030)
9.2 Latin America Nanoemulsion Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanoemulsion Market Size by Country (2019-2024)
9.4 Latin America Nanoemulsion Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanoemulsion Market Size (2019-2030)
10.2 Middle East & Africa Nanoemulsion Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanoemulsion Market Size by Country (2019-2024)
10.4 Middle East & Africa Nanoemulsion Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Detail
11.1.2 Allergan plc Business Overview
11.1.3 Allergan plc Nanoemulsion Introduction
11.1.4 Allergan plc Revenue in Nanoemulsion Business (2019-2024)
11.1.5 Allergan plc Recent Development
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Detail
11.2.2 AbbVie Inc. Business Overview
11.2.3 AbbVie Inc. Nanoemulsion Introduction
11.2.4 AbbVie Inc. Revenue in Nanoemulsion Business (2019-2024)
11.2.5 AbbVie Inc. Recent Development
11.3 AstraZeneca Inc.
11.3.1 AstraZeneca Inc. Company Detail
11.3.2 AstraZeneca Inc. Business Overview
11.3.3 AstraZeneca Inc. Nanoemulsion Introduction
11.3.4 AstraZeneca Inc. Revenue in Nanoemulsion Business (2019-2024)
11.3.5 AstraZeneca Inc. Recent Development
11.4 Fresenius Kabi AG
11.4.1 Fresenius Kabi AG Company Detail
11.4.2 Fresenius Kabi AG Business Overview
11.4.3 Fresenius Kabi AG Nanoemulsion Introduction
11.4.4 Fresenius Kabi AG Revenue in Nanoemulsion Business (2019-2024)
11.4.5 Fresenius Kabi AG Recent Development
11.5 Kaken Pharmaceutical Co., Ltd.
11.5.1 Kaken Pharmaceutical Co., Ltd. Company Detail
11.5.2 Kaken Pharmaceutical Co., Ltd. Business Overview
11.5.3 Kaken Pharmaceutical Co., Ltd. Nanoemulsion Introduction
11.5.4 Kaken Pharmaceutical Co., Ltd. Revenue in Nanoemulsion Business (2019-2024)
11.5.5 Kaken Pharmaceutical Co., Ltd. Recent Development
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Detail
11.6.2 GlaxoSmithKline plc Business Overview
11.6.3 GlaxoSmithKline plc Nanoemulsion Introduction
11.6.4 GlaxoSmithKline plc Revenue in Nanoemulsion Business (2019-2024)
11.6.5 GlaxoSmithKline plc Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Nanoemulsion Introduction
11.7.4 Novartis AG Revenue in Nanoemulsion Business (2019-2024)
11.7.5 Novartis AG Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Nanoemulsion Introduction
11.8.4 Sanofi Revenue in Nanoemulsion Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 B. Braun Melsungen AG.
11.9.1 B. Braun Melsungen AG. Company Detail
11.9.2 B. Braun Melsungen AG. Business Overview
11.9.3 B. Braun Melsungen AG. Nanoemulsion Introduction
11.9.4 B. Braun Melsungen AG. Revenue in Nanoemulsion Business (2019-2024)
11.9.5 B. Braun Melsungen AG. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
